SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-000820
Filing Date
2024-01-08
Accepted
2024-01-08 07:31:19
Documents
14
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K athx20240107_8k.htm   iXBRL 8-K 48217
2 EXHIBIT 2.1 - ASSET PURCHASE AGREEMENT ex_612912.htm EX-2.1 449675
  Complete submission text file 0001437749-24-000820.txt   685716

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA athx-20240105.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE athx-20240105_def.xml EX-101.DEF 10353
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE athx-20240105_lab.xml EX-101.LAB 13836
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE athx-20240105_pre.xml EX-101.PRE 10348
8 EXTRACTED XBRL INSTANCE DOCUMENT athx20240107_8k_htm.xml XML 2311
Mailing Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634
Business Address 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634 216-431-9900
ATHERSYS, INC / NEW (Filer) CIK: 0001368148 (see all company filings)

IRS No.: 204864095 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33876 | Film No.: 24518345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)